Agenda & Speakers

16 Dec
11 Jan
Clinical insights for future perspectives of Lenvatinib role


16 December 2022

7:00pm - 9:00pm (GMT+9)

Opening
Dr. Nuttapong Ngamphaiboon
Dr. Nuttapong Ngamphaiboon
Mahidol University, Thailand
Session 1
Lenvatinib role among TKIs in HCC
Dr. Ruey-Shyang Soong
Dr. Ruey-Shyang Soong
Taipei Municipal WanFang Hospital, Tapiei Medical University, Taiwan
Session 2
Treatment strategy for HCC considering from latest data
Dr. Cheah Soon Keat
Dr. Cheah Soon Keat
Island Hospital, Malaysia
Panel Discussion
Dr. Ruey-Shyang Soong
Dr. Ruey-Shyang Soong
Taipei Municipal WanFang Hospital, Tapiei Medical University, Taiwan
Dr. Nuttapong Ngamphaiboon
Dr. Nuttapong Ngamphaiboon
Mahidol University, Thailand
Dr. Cheah Soon Keat
Dr. Cheah Soon Keat
Island Hospital, Malaysia
Dr. Yong Han Paik
Dr. Yong Han Paik
Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea
Closing
Dr. Yong Han Paik
Dr. Yong Han Paik
Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea
Quality of Life in MBC patients treated with Eribulin


11 January 2023

7:00pm - 8:00pm (GMT+9)

Opening
Prof. Shin-Cheh Chen
Prof. Shin-Cheh Chen
Chang Gung University, Taoyuan, Taiwan
Session
Quality of Life in MBC patients treated with Eribulin
Dr. Yuichiro Kikawa
Dr. Yuichiro Kikawa
Assistant Professor of Breast Surgery, Kansai Medical University, Japan
Q&A
Prof. Shin-Cheh Chen
Prof. Shin-Cheh Chen
Chang Gung University, Taoyuan, Taiwan
Dr. Yuichiro Kikawa
Dr. Yuichiro Kikawa
Assistant Professor of Breast Surgery, Kansai Medical University, Japan
Closing
Prof. Shin-Cheh Chen
Prof. Shin-Cheh Chen
Chang Gung University, Taoyuan, Taiwan
Please contact
[email protected]
if you have any enquiries